Alkermes plc (ALKS) | Stock Overview & Key Data

Alkermes plc | Healthcare

US$31.21

1.93%

| Compare Stocks:

Alkermes plc vs Zoetis Alkermes plc vs Haleon Plc - ADR Alkermes plc vs Elanco Animal Health Alkermes plc vs Lantheus Holdings Alkermes plc vs Prestige Consumer Alkermes plc vs S&P 500 | Market

Alkermes plc Performance Comparison

Loading chart data...

Alkermes plc

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: US$30.52 High: US$31.21

on May 15, 2025

52 Week Range

Low: US$22.90 High: US$36.45

on July 10, 2024

on February 18, 2025

All-Time High: US$98.50 on February 28, 2000

Key Statistics

Market Cap i $5.0B

EPS i 2.10

P/E Ratio (TTM) i 14.58

Forward P/E i 15.23

P/B Ratio i 3.34

PEG Ratio i 15.23

Div. Yield i 0.00%

ROE i 25.71%

Beta i 0.465

Debt to Equity i 4.90

Financial Highlights

Profitability

Gross Margin i 83.95%

Operating Margin i 4.50%

Profit Margin i 23.30%

Returns and Earnings

Return on Assets (TTM) i 11.62%

Return on Equity (TTM) i 25.71%

EBITDA i $466.8M

Net Income (TTM) i $355.7M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Alkermes plc ALKS	5.05B Mid-cap	2.73%	11.70%	-13.06%	10.71%	8.56%	29.11%	3.93%	84.93%
Zoetis ZTS	72.09B Large-cap	-0.83%	7.45%	2.47%	-8.45%	-1.40%	-7.89%	-1.37%	23.23%
Haleon Plc - ADR HLN	48.10B Large-cap	1.04%	5.53%	6.91%	13.74%	13.14%	22.91%	41.16%	41.16%
Elanco Animal Health ELAN	6.40B Mid-cap	5.54%	57.28%	14.49%	-7.30%	7.55%	-24.61%	-46.60%	-31.57%
Lantheus Holdings LNTH	5.50B Mid-cap	-0.78%	-22.35%	-0.16%	3.88%	-10.12%	0.13%	28.06%	528.11%
Prestige Consumer PBH	4.32B Mid-cap	0.22%	7.77%	2.39%	5.91%	12.24%	34.85%	61.41%	106.69%

Ownership & Short Interest

Insider Ownership i 1.48%

Institutional Ownership i 587.06%

Shares Short i 13M

Short Ratio i 6.53

Short % of Shares Outstanding i 11.23%

Average 10-Day Volume i 2M

Average 90-Day Volume i 2M

Alkermes plc Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Alkermes plc would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is ALKS's 52-week high and low?

In the last 52 weeks, Alkermes plc reached a high of US$36.45 (on February 18, 2025) and a low of US$22.90 (on July 10, 2024).

What is the market cap and P/E ratio for ALKS?

Curious about Alkermes plc's size and valuation? Its market capitalization stands at 5.05B. When it comes to valuation, the P/E ratio (trailing twelve months) is 14.58, and the forward P/E (looking ahead) is 15.23.

Does ALKS pay dividends? If so, what's the yield?

As for dividends, Alkermes plc isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Alkermes plc's main competitors or similar companies to consider before investing?

When looking at Alkermes plc, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Zoetis ZTS	72.09B	Healthcare	Drug Manufacturers - Specialty & Generic	-7.89%	-1.37%
Haleon Plc - ADR HLN	48.10B	Healthcare	Drug Manufacturers - Specialty & Generic	22.91%	41.16%
Elanco Animal Health ELAN	6.40B	Healthcare	Drug Manufacturers - Specialty & Generic	-24.61%	-46.60%
Lantheus Holdings LNTH	5.50B	Healthcare	Drug Manufacturers - Specialty & Generic	0.13%	28.06%
Prestige Consumer PBH	4.32B	Healthcare	Drug Manufacturers - Specialty & Generic	34.85%	61.41%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Alkermes plc? (e.g., ROE, Debt/Equity)

To get a sense of Alkermes plc's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 25.71%, the Debt to Equity ratio from the most recent quarter is 4.90, and its Gross Profit Margin stands at 83.95%.

What is the recent revenue and earnings growth for ALKS?

Looking at Alkermes plc's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by -12.50%, and quarterly earnings saw a YoY growth of -39.00%.

How much of ALKS stock is held by insiders and institutions?

Wondering who owns Alkermes plc stock? Company insiders (like executives and directors) hold about 1.48% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 587.06%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.